Journal of Bioequivalence & Bioavailability is a peer reviewed, open access journal dedicated to publishing research on all aspects of Drug Therapeutics.
NRTIs are taken as prodrugs and must be taken into the host cell and phosphorylated before they become active. Once inside the host cell, cellular kinases will activate the #drug.
Drugs often have several names. When a drug is first discovered, it is given a chemical name, which describes the atomic or molecular structure of the drug. The chemical name is usually too complex and cumbersome for general use.
Chemical #drugs have a low molecular weight and derive from a production process based on chemical synthesis starting from compounds which, under defined conditions, give rise to pharmacologically active molecules.
In some cases – often in the #treatment of #disease such as #Cancer, #HIV infection and diabetes – multiple #drugs with different active ingredients may be administered, which is known as combination #therapy.
Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
Anti-infectives are medicines that work to prevent or treat infections, they include antibacterials, antivirals, antifungals and antiparasitic medications.
#pharmacology has been identified as a critical undergraduate degree required to develop new medicines, improve current therapies and to treat #patients.
metformin is used to lower blood sugar levels in diabetes. Metformin is the generic form of a drug which is also available under the brand name Glucophage.
the U.S. Food and Drug Administration approved Xenpozyme (Olipudase alfa) for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD), a rare genetic disease that causes premature #Death.
Tablets may contain one or more of functional ingredients such as diluents (also known as fillers), binders, disintegrants, glidants, lubri-cants, coating materials, coloring agents, stabilizer(s), sweeteners, and fla-voring agents.
A tablet formulation typically comprises one or more active substance(s) and other excipients that are required to enable the pharmacokinetic and mechanical properties of the final dosage form.